Nebulized KELEA Water for COVID-19

N/A

Waitlist Available

Led By W John Martin, MD, PhD

Research Sponsored by Institute of Progressive Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Individuals entering into quarantine because of a positive Covid-19 test using either PCR or an authorized antigen assay

Timeline

Screening 3 weeks

Treatment Varies

Follow Up two consecutive 2-days periods of sequential inhalation of test and control water in randomized order.

Summary

This trial is looking at whether or not inhaling a nebulized mist from water can help lessen symptoms of Covid-19 and if there are any adverse effects.

Who is the study for?

This trial is for people who have tested positive for COVID-19, preferably showing symptoms, and are entering quarantine. They must be willing to undergo repeat PCR or antigen testing and share the results along with their clinical data.

What is being tested?

The study tests inhaling nebulized mist from KELEA Excellerated Water versus regular water without elevated KELEA levels. Participants will use a nebulizer or humidifier over two consecutive days and get tested for COVID-19 after each period.

What are the potential side effects?

There are no known adverse effects reported from inhaling the water mist using a nebulizer or humidifier in this context.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am going into quarantine due to a positive Covid-19 test.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ two consecutive 2-days periods of sequential inhalation of test and control water in randomized order.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~two consecutive 2-days periods of sequential inhalation of test and control water in randomized order.

This trial's timeline: 3 weeks for screening, Varies for treatment, and two consecutive 2-days periods of sequential inhalation of test and control water in randomized order. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Secondary study objectives

Inhalation of KELEA Excellerated Water in Covid-19 Infected Individuals

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Treated Then Control WaterActive Control2 Interventions

This Arm includes half of the total randomly allocated participants in the study. Participants will initially inhale KELEA Excellerated Water for 2 days followed by inhaling water without an elevated level of KELEA for 2 days, with Covid-19 testing and symptom assessments performed at the ends of both of the 2 days periods.

Group II: Control Than Treated WaterPlacebo Group2 Interventions

This Arm includes half of the total randomly allocated participants in the study. Participants will initially inhale water without an elevated level of KELEA for 2 days followed by inhaling KELEA Excellerated water for 2 days, with Covid-19 testing and symptom assessments performed at the ends of both of the 2 days periods.

0 / 1Eligibility criteria met